RATIONALE FOR EARLY USE OF LEVODOPA IN PARKINSONISM
- 15 March 1986
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 327 (8481) , 612-613
- https://doi.org/10.1016/s0140-6736(86)92829-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- COMPLICATED RESPONSE FLUCTUATIONS IN PARKINSON'S DISEASE: RESPONSE TO INTRAVENOUS INFUSION OF LEVODOPAThe Lancet, 1982
- Nonaminergic striatal neurons convert exogenous l‐dopa to dopamine in parkinsonismAnnals of Neurology, 1980
- Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapyNeurology, 1979
- Factors Influencing the Occurrence of “on‐off” Symptoms during Long‐Term Treatment with L‐dopaActa Medica Scandinavica, 1978
- "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPYThe Lancet, 1976
- On‐off responseNeurology, 1975
- SYNTHETIC AMINO ACIDS AND THE NATURE OF l‐DOPA TRANSPORT AT THE BLOOD‐BRAIN BARRIERJournal of Neurochemistry, 1975
- Patterns of clinical response and plasma dopa levels in Parkinson's diseaseNeurology, 1975